| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Endocrine Metabolic and Immune Disorders Drug Targets (Q3) | ||
| Dergi ISSN | 1871-5303 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 07-2021 |
| Cilt / Sayı / Sayfa | 21 / 7 / 1326–1332 | DOI | 10.2174/1871530320666200910110915 |
| Makale Linki | http://dx.doi.org/10.2174/1871530320666200910110915 | ||
| UAK Araştırma Alanları |
Tıbbi Biyoloji
|
||
| Özet |
| Background Fibromyalgia syndrome (FMS) is characterized by widespread musculoskeletal pain. It is more common in women than in men, and sex hormones may play a role in this predominance. Therefore, this research investigated the clinical findings among Turkish females and whether Estrogen-α (ESR1) gene variants are associated with FMS. Methods A total of 219 individuals were enrolled in this study. ESR1 variants (PvuII/XbaI) were genotyped using PCR-RFLP methods. The results of the analyses were evaluated for statistical significance. Results There was a significant association between the ESR1 PvuII and FMS risk among Turkish women. The ESR1 PvuII CC genotype and C allele were higher in the patients than those in the controls (p=0.021, p=0.007, respectively). A more statistically significant association was observed between the patients and the controls in terms of TT genotype vs … |
| Anahtar Kelimeler |
| Estrogen receptor-α | Fibromiyalgia syndrome | Pvull | Variant | Women | XbaI |
| Atıf Sayıları | |
| Web of Science | 3 |
| Scopus | 4 |
| Google Scholar | 7 |
| Dergi Adı | Endocrine Metabolic & Immune Disorders-Drug Targets |
| Yayıncı | Bentham Science Publishers |
| Açık Erişim | Hayır |
| ISSN | 1871-5303 |
| E-ISSN | 2212-3873 |
| CiteScore | 4,4 |
| SJR | 0,535 |
| SNIP | 0,547 |